LDLR and hyperlipidemia: Yu et al. [99] investigated the lipid-lowering effect of CM3-SII, an alkali-extracted polysaccharide from Cordyceps militaris, in a heterozygous low-density lipoprotein receptor (LDLR)-deficient hamster model for hyperlipidemia.